BSE Live
Oct 10, 16:01Prev. Close
20.02
Open Price
20.69
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Key Financial Ratios of Gujarat Inject (Kerala) (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 0.70 | 0.09 | 0.05 | 0.00 | -0.12 | |
Diluted EPS (Rs.) | 0.70 | 0.09 | 0.05 | 0.00 | -0.12 | |
Cash EPS (Rs.) | 0.70 | 0.07 | 0.08 | 0.00 | -0.22 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 6.84 | 7.57 | -1.71 | -1.80 | -1.80 | |
Book Value [InclRevalReserve]/Share (Rs.) | 6.84 | 7.57 | -1.71 | -1.80 | -1.80 | |
Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 13.01 | 5.13 | 0.36 | 0.05 | 0.02 | |
PBDIT/Share (Rs.) | 0.86 | 0.09 | 0.11 | 0.01 | -0.22 | |
PBIT/Share (Rs.) | 0.86 | 0.09 | 0.11 | 0.01 | -0.22 | |
PBT/Share (Rs.) | 0.86 | 0.09 | 0.11 | 0.01 | -0.22 | |
Net Profit/Share (Rs.) | 0.70 | 0.07 | 0.08 | 0.00 | -0.22 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 6.59 | 1.82 | 31.96 | 13.14 | -911.24 | |
PBIT Margin (%) | 6.59 | 1.82 | 31.96 | 13.14 | -911.24 | |
PBT Margin (%) | 6.58 | 1.81 | 31.93 | 13.05 | -911.24 | |
Net Profit Margin (%) | 5.34 | 1.42 | 23.62 | 9.77 | -911.24 | |
Return on Networth / Equity (%) | 10.15 | 0.96 | -4.90 | -0.25 | 0.00 | |
Return on Capital Employed (%) | 12.54 | 1.23 | -14.62 | -0.64 | 22.60 | |
Return on Assets (%) | 8.51 | 0.95 | 13.53 | 3.41 | -599.51 | |
Total Debt/Equity (X) | 0.00 | 0.00 | -0.73 | -0.84 | -0.79 | |
Asset Turnover Ratio (%) | 1.85 | 1.29 | 0.94 | 0.55 | 65.79 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 4.73 | 40.77 | 0.10 | 0.05 | 0.02 | |
Quick Ratio (X) | 4.73 | 40.77 | 0.10 | 0.05 | 0.02 | |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 36.07 | 8.32 | 4.38 | 1.48 | 0.00 | |
EV/Net Operating Revenue (X) | 1.89 | 1.44 | 25.18 | 65.66 | 0.00 | |
EV/EBITDA (X) | 28.73 | 78.68 | 78.78 | 499.58 | 0.00 | |
MarketCap/Net Operating Revenue (X) | 2.00 | 1.94 | 22.04 | 33.50 | 0.00 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 3.80 | 1.31 | -4.57 | -0.86 | 0.00 | |
Price/Net Operating Revenue | 2.00 | 1.94 | 22.08 | 33.70 | 0.00 | |
Earnings Yield | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 |
24.01.2025
Guj Inject Kera Standalone December 2024 Net Sales at Rs 3.15 crore, up 1360.07% Y-o-Y
13.08.2024
Guj Inject Kera Standalone June 2024 Net Sales at Rs 3.05 crore, up 1881.39% Y-o-Y
14.02.2024
Guj Inject Kera Standalone December 2023 Net Sales at Rs 0.22 crore, up 115.04% Y-o-Y
16.08.2023
Guj Inject Kera Standalone June 2023 Net Sales at Rs 0.15 crore, up 272.15% Y-o-Y